Position in UTHR
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$4,129,828
-$312,185 QoQ
Shares Held
7,622
+1.7% QoQ
Ownership
0.018%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
#273
of 870 holders
Holding Since
Jun 2020
23 quarters on record
Voting authority
Sole 77%
Shared 0%
None 23%
Common Shares in UTHR Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026MARTINGALE ASSET MANAGEMENT L P holds $52,615,067 across 17 Drug Manufacturers - Specialty & Generic names. UTHR ranks #4 (7.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
69,799 | $11,763,923 | |
| 2 | ALKS |
Alkermes plc.
|
170,004 | $8,908,209 | |
| 3 | AMRX |
Amneal Pharmaceuticals, Inc.
|
283,033 | $4,899,301 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
This page
|
7,622 | $4,129,828 | |
| 5 | INDV |
Indivior Pharmaceuticals, Inc.
|
85,564 | $3,510,690 | |
| 6 | SUPN |
Supernus Pharmaceuticals, Inc.
|
74,348 | $3,457,925 | |
| 7 | PCRX |
Pacira BioSciences, Inc.
|
112,025 | $2,842,074 | |
| 8 | ANIP |
Ani Pharmaceuticals Inc
|
30,741 | $2,544,739 |
All Filings in UTHR
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,129,828 | 7,622 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $4,442,013 | 7,491 | Shares | Sole | 2026-05-13 | |
| 2025-06-30 | $4,552,486 | 15,843 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $5,178,319 | 16,798 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $12,226,611 | 34,652 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $13,295,501 | 37,102 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $13,623,109 | 42,766 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $11,096,164 | 48,303 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $12,276,018 | 55,828 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $12,666,337 | 56,078 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $13,260,011 | 60,068 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $14,110,375 | 63,004 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $17,031,065 | 61,243 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $13,246,425 | 63,265 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $12,989,655 | 55,125 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $8,758,436 | 48,818 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $7,861,854 | 36,384 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $1,373,274 | 7,440 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $16,035,127 | 89,377 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $16,069,796 | 96,071 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $10,004,630 | 65,911 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $4,273,209 | 42,309 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $1,734,293 | 14,333 | Shares | Sole | 2020-08-10 | |
| No filing history on record for this holder in this stock. | ||||||